NDC 0069-0655 – Talzenna

Talazoparib Tosylate .75 mg/1 · Capsule, Liquid Filled · Oral

Human Prescription Drug

Product NDC0069-0655

Product details

Brand name
Talzenna
Generic name
talazoparib
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
Capsule, Liquid Filled
Route
Oral
Marketing category
NDA · NDA217439
Marketed since
April 17, 2024
Listing expires
December 31, 2027
Pharmacologic class
Poly(ADP-Ribose) Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Talzenna →

Package NDC codes (1)

Package NDCDescriptionSince
0069-0655-3030 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0655-30)Apr 17, 2024

Other Talzenna products